Evidence map›Paper›PMID 40292665›Full record

ArticlePolymers2025

UV-Assisted Material Extrusion Additive Manufacturing of Double-Base Propellant.

Manman Li, Yuchen Gao, Qionglin Wang, Weitao Yang, Guo-Lin Gao, Zaixing Jiang

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manman LiXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Yuchen GaoXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Qionglin WangXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Weitao YangXi'an Modern Chemistry Research Institute, Xi'an 710065, China.
Guo-Lin GaoMIIT Key Laboratory of Critical Materials Technology for New Energy Conversion and Storage, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China.ORCID 0000-0001-5177-9139
Zaixing JiangMIIT Key Laboratory of Critical Materials Technology for New Energy Conversion and Storage, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Double-base (DB) propellants, renowned for their superior performance and cost-effectiveness, are extensively utilized in both rocketry and artillery applications. During the 3D printing process of double-base propellants, auxiliary solvents play a crucial role in plasticizing the DB propellant mixtures. Consequently, the printed propellants are prone to significant shrinkage and dimensional instability as a result of solvent evaporation post-printing. To address these challenges, we have innovated a UV-assisted material extrusion 3D printing technique that preserves the intended geometries of the DB propellant. The results of our printing trials indicate that incorporating an energetic UV-curable resin as a modifier into the DB propellant paste is highly effective. Ultimately, we successfully fabricated a porous propellant cylinder featuring a periodic woodpile structure. Additionally, the internal structure, mechanical properties, combustion characteristics, and in-barrel ballistic performance of the printed propellants have been thoroughly characterized. Our findings underscore that the UV-assisted material extrusion additive manufacturing process confers exceptional properties to the DB propellant.

Indexed as

double-base propellantmaterial extrusionperformancesperiodic woodpile structureUV-assisted 3D printingUV resin

Identifiers

PMID40292665
PMCPMC11944393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.